Eli Lilly
LLY
$15.09 (1.45%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
The Motley Fool • 3 hours ago • LLY
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
Barrons • 5 hours ago • LLY
Lose Weight on Zepbound, Keep It Off With Eli Lilly's New Pill? Data Say That Works.
Zacks Investment Research • 5 hours ago • LLY
3 Momentum Stocks That Could Continue Their Strong Run in 2026
Benzinga • 5 hours ago • LLY
After Wegovy, Zepbound Shots, This Eli Lilly Oral Pill Can Help Maintain Weight Loss
Investors Business Daily • 7 hours ago • LLY
Eli Lilly's Weight-Loss Pill Succeeds In A First-Of-Its-Kind Study
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.